The effect of the 340b drug pricing program on access, out-of-pocket costs, and adherence of oral targeted agents in medicare beneficiaries with advanced prostate cancer
Urologic Oncology: Seminars and Original Investigations(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要